Piperazine

Piperazine

SCHEMBL989787

C1CNCCN1.NC(=S)S

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.43
MAPT P10636 1/20 0.43
PDE4A P27815 1/20 0.43
KDR P35968 1/20 0.43
CXCR4 P61073 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.34
TSHR P16473 1/20 0.33
ATM Q13315 1/20 0.33
ATR Q13535 1/20 0.33
NOS2 P35228 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
KDM4E B2RXH2 1/20 0.30
GAA P10253 1/20 0.30
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL3767537 1.00 HIF1A (0.43) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL28068962 0.97 HIF1A (0.40) HIF1AMAPTPDE4AKDRCXCR4
Aziridine SCHEMBL476461 0.96
Aziridine SCHEMBL6276086 0.96 TSHR (0.36) HIF1AMAPTPDE4AKDRHSD17B10
SCHEMBL28142052 0.91 CXCR4 (0.53) HIF1AMAPTPDE4AKDRCXCR4
SCHEMBL28021595 0.88 CXCR4 (0.50) HIF1AMAPTPDE4AKDRCXCR4
Pyrrolidine SCHEMBL157612 0.87
Piperazine SCHEMBL1132834 0.85 TSHR (0.50) HIF1AMAPTPDE4AKDRCXCR4
Pyrrolidine SCHEMBL14815556 0.84 ALDH1A1 (0.44) MAPTCXCR4SMN1; SMN2HSD17B10ATM
Pyrrolidine SCHEMBL6930404 0.84 ALDH1A1 (0.44) MAPTCXCR4SMN1; SMN2HSD17B10ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4660332-A1 PROCESS FOR SEPARATING RARE-EARTH METALS IN ADMIXTURE IN AQUEOUS SOLUTION SNF SA (FR) 2025-12-10 EP claimed
US-20250369075-A1 PROCESS FOR SEPARATING RARE-EARTH METALS IN ADMIXTURE IN AQUEOUS SOLUTION SNF SA (FR) 2025-12-04 US claimed
EP-4294576-B1 DITHIOCARBAMATE DEPRESSANTS, METHODS AND USES THEREOF IN FROTH FLOTATION MINERAL SEPARATION TESSENDERLO KERLEY INC (US) 2024-12-25 EP claimed
US-20240149277-A1 DITHIOCARBAMATE DEPRESSANTS, METHODS AND USES THEREOF IN FROTH FLOTATION MINERAL SEPARATION TESSENDERLO KERLEY, INC. (US) 2024-05-09 US claimed
CN-114534158-A Composite stabilizer with waste incineration fly ash heavy metal stability 天津壹鸣环境科技股份有限公司 2022-05-27 CN claimed
CN-105143202-B Dithiocarboxylic acid esters having spermicidal activity and process for their preparation 科学与工业研究委员会 2018-08-14 CN claimed
CN-105143202-A Dithiocarboxylic acid esters having spermicidal activity and process for their preparation COUNCIL SCIENT IND RES 2015-12-09 CN claimed
CN-102335494-B Heavy metal stabilizing treatment method for dust containing heavy metals KURITA WATER IND LTD 2015-03-04 CN claimed
CN-103819026-A Resource utilization method of high-concentration ammonia nitrogen waste liquid HUIZHOU TCL ENVIRONMENTAL TECHNOLOGY CO LTD 2014-05-28 CN claimed
CN-103456885-A Uses of dithiocarbamate compounds SONY CORP 2013-12-18 CN claimed
US-20130264545-A2 USES OF DITHIOCARBAMATE COMPOUNDS SONY CORPORATION (JP) 2013-10-10 US claimed
CN-102335494-A Heavy metal stabilizing treatment method for dust containing heavy metals KURITA WATER IND LTD 2012-02-01 CN claimed
US-20110031481-A1 USES OF DITHIOCARBAMATE COMPOUNDS SONY CORPORATION (JP) 2011-02-10 US claimed
CN-101964396-A Use of dithiocarbamate compounds SONY CORP 2011-02-02 CN claimed
EP-2278636-A1 Uses of dithiocarbamate compounds Sony Corporation (JP) 2011-01-26 EP claimed
EP-4660332-A1 PROCESS FOR SEPARATING RARE-EARTH METALS IN ADMIXTURE IN AQUEOUS SOLUTION SNF SA (FR) 2025-12-10 EP disclosed
US-20250369075-A1 PROCESS FOR SEPARATING RARE-EARTH METALS IN ADMIXTURE IN AQUEOUS SOLUTION SNF SA (FR) 2025-12-04 US disclosed
JP-2006000829-A METHOD FOR DETERMINING REQUIRED AMOUNT OF HEAVY METAL TREATING AGENT AND APPARATUS USING THE SAME TOSOH CORP 2006-01-05 JP disclosed
US-20040176504-A1 Additive compound for curing halogenated polymers VANDERBILT CHEMICALS, LLC 2004-09-09 US disclosed
US-4133775-A Dichroic light polarizers stained with metal chelates POLAROID CORPORATION (US) 1979-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176504-A1 Additive compound for curing halogenated polymers XRCC5, NAA15, TERT HIF1A 3137/4885MAPT 3894/4885PDE4A 2910/4885
US-20130264545-A2 USES OF DITHIOCARBAMATE COMPOUNDS DDT, TST, VDAC2 HIF1A 4811/4885MAPT 2350/4885PDE4A 3842/4885
US-20110031481-A1 USES OF DITHIOCARBAMATE COMPOUNDS DDT, TST, VDAC2 HIF1A 4811/4885MAPT 2350/4885PDE4A 3842/4885
US-20240149277-A1 DITHIOCARBAMATE DEPRESSANTS, METHODS AND USES THEREOF IN FROTH FLOTATION MINERAL SEPARATION ACMSD, AP2A1, CA3 HIF1A 765/4885MAPT 503/4885PDE4A 3585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.